Publisher: Icon Group International, Inc.
Category: Prescription Drugs

Prescription Drugs market research reports by Icon Group International, Inc.

(297 reports matching your criteria)
    • The 2025-2030 World Outlook for Human Growth Hormone Drugs

      The 2025-2030 World Outlook for Human Growth Hormone Drugs This study covers the world outlook for human growth hormone drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More

    • The 2025-2030 World Outlook for Bulk Paclitaxel

      The 2025-2030 World Outlook for Bulk Paclitaxel This study covers the world outlook for bulk paclitaxel across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Gynaecological Cancer Drugs

      The 2025-2030 World Outlook for Gynaecological Cancer Drugs This study covers the world outlook for gynaecological cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More

    • The 2025-2030 World Outlook for Contraceptive Pills

      The 2025-2030 World Outlook for Contraceptive Pills This study covers the world outlook for contraceptive pills across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More

    • The 2025-2030 World Outlook for Uveitis Treatments

      The 2025-2030 World Outlook for Uveitis Treatments This study covers the world outlook for uveitis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Pseudomonas Aeruginosa Infection Treatments

      The 2025-2030 World Outlook for Pseudomonas Aeruginosa Infection Treatments This study covers the world outlook for pseudomonas aeruginosa infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More

    • The 2025-2030 World Outlook for Cough Hypersensitive Syndrome Treatments

      The 2025-2030 World Outlook for Cough Hypersensitive Syndrome Treatments This study covers the world outlook for cough hypersensitive syndrome treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More

    • The 2025-2030 World Outlook for Bioidentical Hormones

      The 2025-2030 World Outlook for Bioidentical Hormones This study covers the world outlook for bioidentical hormones across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More

    • The 2025-2030 World Outlook for Alzheimer's Diseases

      The 2025-2030 World Outlook for Alzheimer's Diseases This study covers the world outlook for Alzheimer's diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Opioid Use Disorders

      The 2025-2030 World Outlook for Opioid Use Disorders This study covers the world outlook for opioid use disorders across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Anxiety Disorders and Depression

      The 2025-2030 World Outlook for Anxiety Disorders and Depression This study covers the world outlook for anxiety disorders and depression across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More

    • The 2025-2030 World Outlook for Antiulcerant Drugs

      The 2025-2030 World Outlook for Antiulcerant Drugs This study covers the world outlook for antiulcerant drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More

    • The 2025-2030 World Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema

      The 2025-2030 World Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema This study covers the world outlook for anti-vascular endothelial growth factor therapy (anti-VEGF) for non-infectious macular edema across more than 190 countries. For each y ... Read More

    • The 2025-2030 World Outlook for Antiviral Drugs

      The 2025-2030 World Outlook for Antiviral Drugs This study covers the world outlook for antiviral drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More

    • The 2025-2030 World Outlook for Analgesics (Painkillers)

      The 2025-2030 World Outlook for Analgesics (Painkillers) This study covers the world outlook for analgesics (painkillers) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More

    • The 2025-2030 World Outlook for Germcitabine HCI

      The 2025-2030 World Outlook for Germcitabine HCI This study covers the world outlook for germcitabine HCI across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More

    • The 2025-2030 World Outlook for Cognitive and Memory Enhancer Drugs

      The 2025-2030 World Outlook for Cognitive and Memory Enhancer Drugs This study covers the world outlook for cognitive and memory enhancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More

    • The 2025-2030 World Outlook for Drugs for Rheumatoid Arthritis

      The 2025-2030 World Outlook for Drugs for Rheumatoid Arthritis This study covers the world outlook for drugs for rheumatoid arthritis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Zanamivir Influenza Medications

      The 2025-2030 World Outlook for Zanamivir Influenza Medications This study covers the world outlook for zanamivir influenza medications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More

    • The 2025-2030 World Outlook for Dermatological Drugs

      The 2025-2030 World Outlook for Dermatological Drugs This study covers the world outlook for dermatological drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Children's Medicines

      The 2025-2030 World Outlook for Children's Medicines This study covers the world outlook for children's medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More

    • The 2025-2030 World Outlook for Hospital Acquired Infection Treatments

      The 2025-2030 World Outlook for Hospital Acquired Infection Treatments This study covers the world outlook for hospital acquired infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More

    • The 2025-2030 World Outlook for Hospital Acquired Infections Testing

      The 2025-2030 World Outlook for Hospital Acquired Infections Testing This study covers the world outlook for hospital acquired infections testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More

    • The 2025-2030 World Outlook for Peripheral Neuritis Treatments

      The 2025-2030 World Outlook for Peripheral Neuritis Treatments This study covers the world outlook for peripheral neuritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More

    • The 2025-2030 World Outlook for Myasthenia Gravis Treatments

      The 2025-2030 World Outlook for Myasthenia Gravis Treatments This study covers the world outlook for myasthenia gravis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More

5 6 7 8 9 10 11 12

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings